At Creative Proteomics, we are at the forefront of peptidomics-based drug target research, harnessing advanced methodologies and cutting-edge technologies to drive innovation in the field of drug development. Our comprehensive understanding of proteomics, particularly peptidomics, enables us to offer unparalleled insights into the identification, characterization, and validation of potential drug targets, ultimately contributing to the advancement of therapeutic strategies for various diseases. In this comprehensive service page, we delve into the world of peptidomics-based drug target research, from its overview to analysis methods, advantages, techniques, instrumentation, and diverse applications.
Peptidomics-Based Drug Target Research Solutions
Peptidomics entails the comprehensive investigation of endogenous peptides that reside within a biological framework. In the realm of drug target research, peptidomics primarily centers on the identification and characterization of peptides that possess the potential to be exploited as targets for therapeutic intervention. Through unraveling the complex interconnectedness of peptide signaling, peptidomics assumes a vital role in the identification of prospective targets for drug development across a diverse spectrum of disease domains, encompassing cancer, neurodegenerative ailments, metabolic disorders, and infectious maladies.
Key Focus:
- Identifying New Drug Targets
Our peptidomics research helps in identifying and characterizing peptides that are involved in various biological processes.
- Disease Mechanisms Study
By studying the peptidome, researchers can gain insights into the molecular mechanisms underlying various diseases.
- Drug Repurposing
Our scientists use peptidomics to reveal new functions and interactions of existing drugs, thereby repurposing them for different therapeutic indications. By understanding the peptide group and its role in disease pathways, our scientists can identify existing drugs that may have potential efficacy against different diseases.
- Peptide-Based Therapeutic Development
Our scientists guide the design and development of peptide-based therapeutics through peptidomics research. Peptides can be modified to improve their stability, potency, and selectivity, making them ideal candidates for drug discovery and development.
- Resistance Studies
Peptide analysis helps understand resistance mechanisms. By studying changes in the peptidome, our scientists identify the development of drug-resistant phenotypes and design strategies to overcome drug resistance.
Our Techniques in Drug Target Research
- NanoLC-MS/MS
Our advanced nano liquid chromatography-tandem mass spectrometry (nanoLC-MS/MS) platforms enable the sensitive and high-resolution analysis of complex peptide mixtures, empowering the identification of potential drug targets with exceptional accuracy.
- MALDI-TOF/TOF MS
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF/TOF MS) techniques, coupled with our cutting-edge instrumentation, provide rapid and precise peptide analysis, facilitating the discovery of novel drug targets in diverse biological samples.
- High-Resolution Mass Spectrometry
Employing high-resolution mass spectrometry, we ensure unparalleled sensitivity and specificity in peptidomics-based drug target research, enabling the precise characterization and quantification of endogenous peptides critical for therapeutic interventions.
Peptidomics-Based Drug Target
| Receptors |
Application Fields |
| Neuropeptide Y receptor |
Drugs targeting this receptor are being developed for the treatment of obesity and metabolic disorders. |
| Opioid receptors |
Drugs targeting these receptors are used for the management of pain and addiction. |
| Somatostatin receptors |
Drugs targeting somatostatin receptors are used for the treatment of conditions like acromegaly, neuroendocrine tumors, and gastrointestinal disorders. |
| Vasopressin receptors |
Drugs targeting vasopressin receptors are used for the treatment of conditions like diabetes insipidus, nocturia, and hyponatremia. |
| Cholecystokinin receptors |
Drugs targeting cholecystokinin receptors are being investigated for the treatment of conditions like obesity and gastrointestinal disorders. |
| Ghrelin receptors |
Drugs targeting ghrelin receptors are being studied for the treatment of obesity and cachexia. |
| Calcitonin gene-related peptide (CGRP) receptor |
Drugs targeting the CGRP receptor are being developed for the treatment of migraines. |
| Substance P receptor |
Drugs targeting somatostatin receptors are used for the treatment of conditions like acromegaly, neuroendocrine tumors, and gastrointestinal disorders. |
| Bombesin receptors |
Drugs targeting bombesin receptors are being studied for the treatment of obesity and gastrointestinal disorders. |
At Creative Proteomics, our commitment lies in empowering researchers, pharmaceutical developers, and biotechnologists with the most advanced peptidomics analysis techniques available. Through our services, we aim to accelerate advancements in animal health, drug development, and basic biological research. Please contact us today and unlock the potential of peptide analysis.
* For research use only. Not for use in diagnostic procedures!
Our customer service representatives are available 24 hours a day, 7 days a
week.
